Exosomes derived from BMSCs alleviates high glucose‐induced diabetic retinopathy via carrying miR‐483‐5p
Authors:
- 9 December 2023
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 38 (1) , e23616
Abstract
Diabetic retinopathy (DR) is a progressive disease which can cause health problem. It has been reported that bone marrow mesenchymal stem cells (BMSCs)‐secreted exosomes could regulate the progression of DR via carrying microRNAs. Meanwhile, miR‐483‐5p was downregulated in DR; however, whether BMSCs‐secreted exosomes can modulate DR progression via carrying miR‐483‐5p remains unclear. To mimic DR in vitro, ARPE‐19 cells were exposed to 30 mM high glucose (HG). Exosomes were isolated from BMSCs and identified by transmission electron microscopy, nanoparticle tracking analysis, and western blot. Cell counting kit‐8 assay was applied for assessing the cell viability. Flow cytometry was applied to test the cell apoptosis. Meanwhile, dual luciferase assay was used to evaluate the association among miR‐483‐5p and downstream target insulin‐like growth factor 1 receptor (IGF‐1R). In addition, quantitative reverse‐transcription polymerase chain reaction and western blot were used for exploring the level of miR‐483‐5p and IGF‐1R. HG significantly induced apoptosis in ARPE‐19 cells, while BMSCs‐derived exosomes reversed this phenomenon. In addition, inhibition of miR‐483‐5p expression of exosomes further aggravated HG‐induced ARPE‐19 cell apoptosis. Meanwhile, IGF‐1R was the downstream messenger RNA of miR‐483‐5p, and IGF‐1R silencing could reverse the effect of exosomes with downregulated miR‐483‐5p on HG‐induced cell injury. Exosomes derived from BMSCs inhibit the progression of DR via carrying miR‐483‐5p. Thus, our study might provide a theoretical basis for discovering new strategies against DR.Keywords
Funding Information
- National Natural Science Foundation of China (81200697)
This publication has 35 references indexed in Scilit:
- Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathologyJournal of Neuroinflammation, 2022
- Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P1 in diabetic retinopathyMolecular Therapy Nucleic Acids, 2021
- Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2Bioengineered, 2021
- MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axisLife Sciences, 2021
- Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repressionJournal of Endocrinological Investigation, 2020
- RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathyAmerican Journal of Physiology-Endocrinology and Metabolism, 2018
- The quinic acid derivative KZ-41 prevents glucose-induced caspase-3 activation in retinal endothelial cells through an IGF-1 receptor dependent mechanismPLOS ONE, 2017
- Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic RatsPLOS ONE, 2016
- Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatmentNeural Regeneration Research, 2016
- Insulin glargine and receptor‐mediated signalling: clinical implications in treating type 2 diabetesDiabetes/Metabolism Research and Reviews, 2007